Senti Biosciences, Inc.
SNTI
$2.08
-$0.02-0.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.89% | -2.40% | 14.98% | 25.71% | -0.49% |
| Total Depreciation and Amortization | -3.93% | -19.05% | -21.55% | -19.69% | -10.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -146.28% | 1,634.15% | -13.29% | -83.57% | 146.68% |
| Change in Net Operating Assets | -85.62% | -108.58% | -56.70% | 20.58% | 245.73% |
| Cash from Operations | -43.35% | -14.25% | 8.39% | 20.99% | 35.75% |
| Capital Expenditure | -989.47% | 88.97% | 99.80% | 99.78% | 99.91% |
| Sale of Property, Plant, and Equipment | -92.73% | -31.43% | -42.86% | -42.86% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -233.56% | -100.64% | -99.88% | -99.89% | 100.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 72.94% |
| Issuance of Common Stock | 8,341.26% | 8,465.28% | 5,430.89% | 5,430.89% | -50.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.68% | -- | -- | -- | -- |
| Cash from Financing | 1,636.01% | 10,092.68% | 6,449.88% | 6,797.30% | 172.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 105.48% | 127.56% | 229.73% | 157.42% | 56.10% |